The FDA has renewed a warning about the potential for dosing errors with liquid acetaminophen products for infants. FDA advisory committees made recommendations in 2009 that all liquid acetaminophen be produced in a single concentration: 160mg/5mL. The recommendation was voluntary and not all manufacturers have followed it so there are still products with strengths of…
DetailsA recent study showed Multaq doubled the risk of heart-related complications in patients with permanent atrial fibrillation. The study, conducted bythe drugmaker, Sanofi, showed higher rates of heart attack, stroke and death in certain patients. While the FDA did not remove Multaq from the market, they recommended restricting the use of the drug to patients…
DetailsThe Food and Drug Administration last week posted a warning on its website against homeopathic products containing the hormone human chorionic gonadotropin (hCG) that are used for weight loss with severe 500-calories-per-day dieting. The agency also notes that a 500-calorie-a-day diet poses a variety of health risks, including malnutrition, gallstones, electrolyte imbalance and irregular heartbeat.…
DetailsNBC Nightly News (12/8, story 7, 2:20, Williams) reported, “Medical experts have been taking…[a] look at Drospirenone/Ethinyl Estradiol [Yaz], because of studies that show they may be more likely to cause dangerous blood clots than older versions of the” medication. Chief Medical Editor Dr. Nancy Snyderman said, “Two of the most popular birth control” medications…
DetailsOver the counter weight loss products containing human chorionic gonadotropin (HCG) have been declared fraudulent and illegal by the FDA and the Federal Trade Commission. The agencies have told seven manufacturers to stop selling them. The warning letters sent t manufacturers note that HCG has not received FDA approval for any weight-loss indication. It has…
DetailsResearch suggesting that the newer birth control formulations are more likely to cause blood clots that the older drugs has prompted the Food and Drug Administration to consider new safety measures. Yaz, Yasmin and other pills containing a synthetic hormone called drospirenone as well as the Ortho Evra patch which uses the hormone norelgestromin are…
DetailsBBC News in Liverpool reported that more than 100 people , most from Merseyside, are suing DePuy over the effects of hip implants that were withdrawn in August 2010. Over 2,000 cases have been filed against Depuy over the ASR in the U.S.
BBC News in Liverpool reported that more than 100 people , most from Merseyside, are suing DePuy over the effects of hip implants that were withdrawn in August 2010. Over 2,000 cases have been filed against Depuy over the ASR in the U.S.
In September, The FDA’s Reproductive Health Drugs Advisory Committee and the Drug safety and Risk Management Advisory Committee held a joint meeting to discuss the appropriate duration of use for Fosamax and other bisphosphonates. Earlier this year the FDA required manufacturers to include language in their labels stating that the optimal duration for patient use…
DetailsThe FDA has ordered a review of all metal-on-metal hip implants due to mounting patient complaints. Problems include loosening, fracturing and dislocating of the device caused by inflammation in the joint space. In addition many patients have experienced soft tissue damage and metal poisoning because these devices can shed particles of chromium and cobalt into…
Details